#osteomyelitis — Monday, February 02, 2026 (1 items)
| 0 | 💬 0 |
Real-world drug monitoring of dalbavancin using a three-dose regimen of 1500 mg at days 1, 15 and 43 in bone and joint or cardiovascular infection.
(academic.oup.com)
|
Journal of Antimicrobial Chemotherapy 2026-02-02 | #pharmacokinetics #infection #therapeutic drug monitoring #endocarditis #osteomyelitis |